Compare Capri Holdings Ltd (CPRI) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Capri Holdings Ltd vs Recursion Pharmaceuticals Inc — how do they compare? Capri Holdings Ltd trades at $15.62 (market cap $1.75B), while Recursion Pharmaceuticals Inc trades at $3.35 (market cap $1.81B). The key difference: Capri Holdings Ltd and Recursion Pharmaceuticals Inc are close in size by market cap. Which is the better fit depends on your goals.
| CPRI | RXRX | |
|---|---|---|
Market Cap | $1.75B | $1.81B |
Sector | Consumer Staples | Health |
52-Week High | $27.66 | $6.79 |
52-Week Low | $14.98 | $2.84 |
Enterprise Value | $3.03B | $1.33B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Capri Holdings Ltd
Michael Kors, Versace, and Jimmy Choo are the brands of Capri Holdings, a marketer, distributor, and retailer of upscale accessories and apparel. Kors, Capri's largest brand, offers handbags, footwear, and apparel through more than 800 company-owned stores, wholesale, and e-commerce. Versace (acquired in 2018) is known for its ready-to-wear luxury fashion, while Jimmy Choo (acquired in 2017) is best known for women's luxury footwear. John Idol has served as CEO since 2003.
Read more on CPRI →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
